Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress
Provided By GlobeNewswire
Last update: Jun 4, 2024
NORCROSS, Ga., June 04, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today announced that it will attend the EASL 2024 meeting and deliver a scientific presentation. The meeting will be held June 5-8, 2024, in Milan, Italy.
